4//SEC Filing
FRESENIUS MEDICAL CARE HOLDINGS INC /NY/ 4
Accession 0001104659-25-119241
CIK 0001818382operating
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 2:20 PM ET
Size
5.9 KB
Accession
0001104659-25-119241
Insider Transaction Report
Form 4
Humacyte, Inc.HUMA
Holdings
- 18,312,735
Common Stock, par value $0.0001 per share
Footnotes (3)
- [F1]Excludes the Reporting Person's pro rata share of up to 15,000,000 additional shares of the Issuer's Common Stock which may become issuable to the former shareholders of Humacyte, Inc. pursuant to the terms of the Business Combination Agreement dated as of February 17, 2021 by and among the Issuer, Hunter Merger Sub, Inc. and Humacyte, Inc., as to which the Reporting Person disclaims any present beneficial ownership interest.
- [F2]This Form 4 is being filed solely to report that the Reporting Person is no longer subject to Section 16. (See the checkbox on page 1.) The decrease in the Reporting Person's beneficial ownership to less than 10% is solely the result of an increase in the number of outstanding shares of the Issuer's Common Stock subsequent to the filing of the Reporting Person's Initial Statement of Beneficial Ownership on Form 3. Neither of the Reporting Person nor FME (see note 3) has disposed of or acquired any shares of the Issuer's Common Stock subsequent to the filing of such Form 3 on September 2, 2021.
- [F3]Fresenius Medical Care Holdings, Inc. is an indirect, wholly-owned subsidiary of Fresenius Medical Care AG ("FME"). FME's address is Else-Kroner Strasse 1, 61352 Bad Homburg, Germany.
Documents
Issuer
Humacyte, Inc.
CIK 0001818382
Entity typeoperating
IncorporatedNY
Related Parties
1- filerCIK 0000042872
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 2:20 PM ET
- Size
- 5.9 KB